• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies

$250.00 – $3,395.00

Clear
SKU: KLI2155316 Categories: Clinical Chemistry, Diagnostics Market Research, Immunoassays, Oncology & Hematology Market Reports, Point-of-Care Diagnostics Pages: 115
  • Description
  • Table of Contents
  • Latest reports

Description

It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information’s lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen’s new report In Vitro Diagnostics in a Recessionary Economy.

The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro diagnostic companies? What are the best areas of IVD and the best world markets? How should companies price and market their products? What are key companies in the market doing at this time? Among the topics covered in this report:

  • Current Market Estimates for Major Categories of IVD.
  • Category Forecasts to 2014
  • Hospital Woes, Uninsured Patients, Payor Stress, and Other Trends industry observers need to know about.
  • Current World Economic Conditions US, Europe and Emerging Markets
  • Obama Administration Healthcare Reform Boom or Bust for IVD?
  • Mergers and Acquisitions: Abbot – Ibis, QIAGEN – Corbett Life Science, J&J / Amic and several other competitive moves.
  • Collaborations: Luminex and BD Tripath, Geisinger Health System and Celera, Sysmex and Epigenomics and other partnerships enacted as companies pool limited resources.
  • Market Expansions: StatSensor Creatinine Meter (TM), Dako and BMS partnership and Others.
  • New Testing Products Launched: BD Focal Point, Aureon’s Prostate Px , New Abbott Marker for AKI and other new tests.
  • Lab Service Commercialization Activities
  • Lab IT Activity and the Involvement of High Tech Players such as Google and IBM.
  • Success Strategies That are Working in 2009

Shara Rosen goes beyond just assessing the market and presents actions that IVD companies can take to assure growth in uncertain times. The report has a special focuses on developments in the United States since this is the largest single market for IVD products, but there is discussion of emerging world markets as well. The following companies who have engaged in relevant competitive activities in recent months were profiled in this report:

  • Abbott Diagnostics
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company (BD)
  • bioMerieux Inc.
  • Celera Corporation
  • Cellestis Ltd
  • Cepheid
  • Clarient Inc. (formerly ChromaVision)
  • deCode Genetics Inc.
  • Genomic Health
  • Gen-Probe Inc.
  • Immucor, Inc.
  • Inverness Medical Innovations
  • Luminex Corporation
  • Monogram Biosciences, Inc.
  • Nanogen
  • Ortho Clinical Diagnostics (OCD)
  • Qiagen N.V.
  • Quidel Corporation
  • Roche Diagnostics
  • Seegene, Inc.
  • Sequenom, Inc.
  • Siemens Medical Solutions Diagnostics
  • Sysmex Corporation
  • Vermillion/Ciphergen Biosystems Inc.

This Kalorama Information report is a work of primary research. Although secondary sources were used, the analyst’s years of experience, interviews with industry experts and the latest findings of the 2009 Diagnostic Marketing Association Conference in Chicago IL were part of this report’s foundation.

Table of Contents

    Clinical Laboratory Services Market, 8th Edition
    May 16, 2023
    Clinical Laboratory Services Market, 7th Edition
    June 28, 2022
    The World Market for Veterinary Diagnostics, 5th Edition
    February 23, 2022
    Clinical Laboratory Services Market, 6th Edition
    June 8, 2021

Related products

  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • New Kalorama Report Pegs Clinical Lab Services Market at 168BN May 18, 2023
  • WHO Reports Lowered Threat Level of COVID-19; What Does it Mean for Testing? May 9, 2023
  • SDi Releases Flagship Market Research Report on Analytical and Life Science Instruments: The Global Assessment Report May 3, 2023
  • Despite Declines, COVID-19 Still a Large IVD Market May 1, 2023
  • Single Cell Genomics Market Reaches $1 Billion April 27, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Pharmaceutical Markets in IndiaWorld Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The
Scroll to top